Catalyst Pharmaceuticals, Inc. Gross Profit 2002–2025
Catalyst Pharmaceuticals, Inc. reported $501.74M of gross profit for fiscal 2025. That was 18.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +391.7%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $501.74M | 85.2% | +18.6% |
| FY 2024 | $422.89M | 86.0% | +22.1% |
| FY 2023 | $346.24M | 86.9% | +92.6% |
| FY 2022 | $179.81M | 83.9% | +51.2% |
| FY 2021 | $118.95M | 84.5% | +16.6% |
| FY 2020 | $102.03M | 85.7% | +16.5% |
| FY 2019 | $87.55M | 85.6% | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
| FY 2016 | — | — | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
| FY 2008 | — | — | — |
| FY 2007 | — | — | — |
| FY 2006 | — | — | — |
| FY 2005 | — | — | — |
| FY 2004 | — | — | — |
| FY 2003 | — | — | — |
| FY 2002 | — | — | — |
Source: Catalyst Pharmaceuticals, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CPRX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Catalyst Pharmaceuticals, Inc. reported $501.74M of gross profit for fiscal 2025. That was 18.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +391.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Catalyst Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCatalyst Pharmaceuticals, Inc. — frequently asked questions
What is Catalyst Pharmaceuticals, Inc.'s gross profit?
Catalyst Pharmaceuticals, Inc. (CPRX) reported gross profit of $501.74M for fiscal year 2025, per its SEC filings.
How has Catalyst Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2002 and 2025, CPRX's gross profit grew at roughly 7.9% per year (compound annual rate), from $87.55M to $501.74M.
Where does this data come from?
Figures are computed from Catalyst Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.